Human Metabolome Technologies America, Inc.
Boston, MA
- UEI
- VAFDJNFJ69S6
- CAGE
- 71VC4
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 24 Denby Rd #217, Allston, MA 02134, USA
- Website
- humanmetabolome.com
- Founded
- 2003
- Employees
- 51-250
- Estimated annual revenue
- $250M-$500M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Biotechnology
- SIC code
- 87 Engineering & Management Services
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| The national institute on alcohol abuse and alcoholism (niaaa), national institutes of health (NIH), conducts studies to… | Office of Logisitics and Acquisition Operations | $17,000 | |
| Nichd: service: samples analysis | National Institute of Child Health and Human Development | $24,220 | |
| Laboratory testing | National Cancer Institute | $23,520 | |
| Laboratory and testing services - omega scan included Q110 option/no cost. | National Cancer Institute | $14,700 | |
| Testing services | National Cancer Institute | $17,640 |
About Human Metabolome Technologies America, Inc.
Human Metabolome Technologies America, Inc. provides metabolomic and lipidomic analytical testing services to the National Institutes of Health as a prime contractor, competing in full-and-open procurements without set-aside designation. The firm is self-certified as a small disadvantaged business and operates from Allston, Massachusetts, though source descriptions identify it as Japan-based; it competes entirely as a prime on small purchase orders under primary PSC Reference Laboratory Testing and NAICS codes in biotechnology research and development and testing laboratory services.
Human Metabolome Technologies America concentrates heavily on NIH biomedical research customers. The top five funding agencies account for 86% of awards by count and 90% by potential value, with the National Cancer Institute dominating both metrics at 35 awards worth $464 thousand combined potential value. The National Heart Lung and Blood Institute (10 awards, $123 thousand), the National Institute on Drug Abuse (5 awards, $369 thousand), the National Institute of Child Health and Human Development (3 awards, $56 thousand), and the National Institute on Alcohol Abuse and Alcoholism (2 awards, $37 thousand) complete the active set. The dollar rankings diverge slightly from volume — the National Institute on Drug Abuse carries higher average award values than the National Heart Lung and Blood Institute — but the National Cancer Institute anchors both dimensions decisively.
The vendor's capability portfolio centers on metabolomic and lipidomic analysis, basic-scan metabolomics, liquid chromatography–mass spectrometry (LC-MS and CE-MS) data acquisition, and laboratory testing services in support of cancer, substance abuse, heart and lung disease, child health, and craniofacial research programs. Representative work includes a $24,220 samples-analysis purchase order from the National Institute of Child Health and Human Development awarded February 2025, a $23,520 laboratory testing order from the National Cancer Institute for August–November 2023, a $19,500 metabolomics and lipidomics analysis service order from the National Institute on Alcohol Abuse and Alcoholism for March–June 2022, and a $17,000 metabolomic analytical services order from the National Institute on Alcohol Abuse and Alcoholism awarded June 2026 with completion by June 2027. All awards are firm fixed-price purchase orders; no parent IDVs, GWACs, BPAs, or master service agreements appear in the source.
Activity has been sparse and episodic. Sixty-four awards over twelve years of sourcing data (2014–2026) yielded only one award each in 2025 and 2026, down from a three-award 2021. Only one award faces ultimate completion inside the next twenty-four months ($17 thousand, the June 2026 NIAAA order), presenting minimal recompete exposure in that window. The vendor holds no subcontract footprint in the source data — all sixty-four awards are prime contracts — and sits on no named federal vehicles or consortia relationships.
Quick answers
What is Human Metabolome Technologies America, Inc.'s UEI?
Human Metabolome Technologies America, Inc.'s Unique Entity ID (UEI) in SAM.gov is VAFDJNFJ69S6.
What is Human Metabolome Technologies America, Inc.'s CAGE code?
Human Metabolome Technologies America, Inc.'s CAGE code is 71VC4.
What is Human Metabolome Technologies America, Inc.'s primary NAICS code?
Human Metabolome Technologies America, Inc.'s primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).
Where is Human Metabolome Technologies America, Inc. located?
Human Metabolome Technologies America, Inc.'s physical address in SAM.gov is 24 Denby Rd #217, Allston, MA 02134, USA.
Is Human Metabolome Technologies America, Inc. registered in SAM.gov?
Yes. Human Metabolome Technologies America, Inc.'s SAM.gov registration is active through June 28, 2027.
What is Human Metabolome Technologies America, Inc.'s most recent federal award?
Human Metabolome Technologies America, Inc.'s most recent federal contract award is The national institute on alcohol abuse and alcoholism (niaaa), national institutes of health (NIH), conducts studies to… (75N98026P00773), from Office of Logisitics and Acquisition Operations, on June 18, 2026.
On GovTribe
See Human Metabolome Technologies America, Inc.'s full federal record
- Federal contract awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors